Disclosure Category Archives — Page 2 of 64 — DC Medical Malpractice & Patient Safety Blog Published by Washington, D.C. Personal Injury Lawyers

March 14, 2021

A year after pandemic began, mourning and reasons for guarded optimism

The national vaccination campaign has picked up measurable momentum. Coronavirus cases, hospitalizations, and deaths continue to recede from scary winter highs. Even cautious state and local officials are easing public health restrictions.

Can it be that the pandemic will be enough in check that Americans can look forward to small family barbecues for the Fourth of July?

President Biden, in his first national broadcast address on the anniversary of the global declaration of a coronavirus pandemic, described that goal as he talked both about the national and personal sorrow of dealing with the worst public health catastrophe in a century while also seeing palpable progress in reining in the disaster.

March 9, 2021

Insurers and employers could save $352 billion if hospitals stuck to Medicare rates

by Patrick A. Malone

Who wouldn’t want $352 billion in health care savings in 2021?

Insurers — and more importantly employers — could see that hypothetical big chunk of change staying in their pockets, if somehow they could persuade hospitals to forgo their sky-high and ever-increasing prices, tying those charges instead to rates established and paid in the federal Medicare program that covers millions of the nation’s seniors, a new study reported.

The independent Kaiser Family Foundation (KFF) concedes it is unlikely that hospitals, insurers, and businesses would adopt the nonprofit organization’s newly published research any time soon.

March 7, 2021

While experts say pandemic is far from over, ‘Neanderthal thinking’ booms

by Patrick A. Malone

The nation has made significant progress, but the coronavirus pandemic is far from over, President Biden and top medical scientists say. That has not stopped a panoply of politicians from coast to coast from declaring a premature victory over the disease that has killed more than 520,000 Americans and infected 29 million people.

As infections, hospitalizations, and deaths have declined from scary peaks of recent months but still plateaued, governors in Texas and Mississippi rescinded coronavirus restrictions, abolishing mask requirements and allowing businesses to operate at 100% capacity.

Biden called the decisions “Neanderthal thinking.”

February 24, 2021

To rein in health costs, experts focus on $1.2 trillion in U.S. hospital spending

by Patrick A. Malone

Although politicians have obsessed for a decade about affordable health insurance, frustrated patients have seen little or no relief on another crucial concern — the skyrocketing costs of medical services. What policy paths could best offer dollars-and-cents help to struggling people with health care prices?

New research from the independent, nonpartisan RAND Corporation offers intriguing clues about billions of dollars in annual savings, based on complex modeling of actual options confronting the public and policy makers.

These choices, the experts say, may come to the political fore with new force due to the economic shocks the U.S. health system has been hit with due to the coronavirus pandemic.

February 22, 2021

Big freeze heats up need for emergency plans for individuals and institutions

by Patrick A. Malone

The climate change deniers can holler their heads off. But for all too many people from coast-to-coast, Mother Nature’s fury is tragically clear — as is the importance of not only future thinking but also emergency planning, by individuals and institutions.

This includes knowing common sense steps to safeguard one’s self and loved ones, in unusual circumstance, from misuse and abuse of ordinary products that also may have their own shortcomings, defects, or dangers.

Huge hurrahs, of course, are in order for the overworked, overstressed, and valiant doctors, nurses, and other health workers who — even while battling the over load of the coronavirus pandemic — have kept up medical services in hard hit areas of Texas and elsewhere during a brutal winter storm and its harsh freeze. The nightmarish conditions afflicted not only big hospitals but also those who provide desperately needed at-home care to the vulnerable.

February 21, 2021

Weather delays and public confusion keep rollout choppy for virus vaccines

by Patrick A. Malone

The national campaign to quash the coronavirus pandemic with what appears to be a highly safe and effective means — new vaccines — has hit more chop as the Biden Administration pushes to increase supplies, sites, and credible public information about the shots.

While the White House has worked with makers to boost the complex production of vaccines and officials are ferreting out unused stashes, demand still exceeds supplies, and rotten weather in the central part of the country disrupted deliveries of millions of shots, causing coast-to-coast cancellations of appointments for patients hoping to get shots. This snag affected the region around Washington, D.C.

The White House has said the supply chains will be restored, pronto.

February 18, 2021

As vehicle makers race into future, whither road- and product-safety issues?

by Patrick A. Malone

The race to deal with the existential threat of climate change by making millions of vehicles smarter, more efficient, and environmentally friendly may be on a collision course with safety concerns.

As the Los Angeles Times reported, concerns are rising among consumer advocates that makers have zoomed ahead with entrepreneurial and engineering advancements in vehicles, even as expert regulators went AWOL in the era of the business-enthralled 45^th president.

Whither the future of road- and product-safety in an era of autonomous or self-driving and all electric vehicles?

February 17, 2021

Big Pharma’s twist: Billions in opioid settlements convert into huge tax breaks

by Patrick A. Malone

While too many Americans struggle with skyrocketing prescription drug costs, so much so that a $10 insurance co-payment may be lethally dissuasive, Big Pharma firms are seeking billions of dollars in taxpayer-funded benefits on giant settlements they made for their role in the opioid abuse and drug overdose crisis.

Johnson & Johnson and the “big three” distributors of prescription drugs — McKesson, AmerisourceBergen and Cardinal Health — have disclosed that they will take tax deductions on sums they will fork over to states, local governments, Indian tribes, and others that sued them over damages that they say occurred after they flooded the country with powerful painkillers, the Washington Post reported.

The four companies have agreed to pay between $5 billion and $8 billion each to reimburse communities for the costs they suffered in dealing with millions of deaths, addictions, and debilitations caused by opioids, their synthetic versions, and illicit drugs they opened the door to.

February 16, 2021

Nursing home coronavirus cases and deaths decline as vaccinations increase

by Patrick A. Malone

The campaign to vaccinate millions of residents and staff in the nation’s thousands of nursing homes and other long-term care facilities against the coronavirus is gaining momentum and showing early, positive effects.

At the same time, however, information is emerging on shabby treatment of the vulnerable, including their exposure to illness exported into their facilities from hospitals, explaining the increasing number of civil lawsuits that owners and operators face.

Good news has been so rare with the pandemic that it may be worth considering first the coast-to-coast drive for long-term care facility vaccinations.

February 12, 2021

Beware of toxic heavy metals in baby foods, congressional group warns

by Patrick A. Malone

Although parents exult when their babies start eating solids, moms and dads may be dishing up for their little darlings unexpected and harmful ingredients in commercially prepared foods — heavy metals, including arsenic, cadmium, and lead at levels that may exceed federal limits.

A subcommittee of the House Committee on Oversight and Reform received lots of media attention when it publicly reported its findings on problems it says it sees with baby products from the likes of Gerber, Walmart, Campbell Soup, and Sprout organics.

Some of the makers, at the panel’s request, provided data on their products and testing for toxins, while others declined the disclosure of did not respond. As the Washington Post reported: